Abstract
COVID-19 positive patients can egest live SARS-CoV-2 virus and viral genome fragments through faecal matter and urine, raising concerns about viral transmission through faecal-oral route and/or contaminated aerosolized water. These worries are heightened in many low and middle income nations, where raw sewage is often dumped into surface waterways and open defecation betide. In this manuscript, we attempt to discern the presence of SARS-CoV-2 genetic material (ORF-1ab, N and S genes) in two urban cities of India viz., Ahmedabad, in western India with several WWTPs; and Guwahati in the north-eastern part of the country with no such treatment plants. The study was carried out to establish applicability of WBE for COVID-19 surveillance as a potential tool for public health monitoring at the community level. 25.8% and 20% of the surface water samples had detectable SARS-CoV-2 RNA load in Ahmedabad and Guwahati, respectively. The high concentration of gene (ORF-1ab – 800 copies/L for Sabarmati river, Ahmedabad and S-gene – 565 copies/L for Bharalu urban river, Guwahati) found in natural waters indicates WWTPs do not always completely remove the genetic material of the virus. The study shows the applicability of WBE surveillance of COVID-19 in cities with low sanitation as well as in rural areas. The method used in this study cannot detect the live viruses, hence further research is required to evaluate the transmission implication of COVID-19 via ambient water, if any.
Highlights
Natural urban waters show the presence of SARS-CoV-2 RNA.
Lake water receiving runoff containing SARS-CoV-2 genes reflected positive sign early
Viral RNA in surface water reflects incomplete removal of gene fragments in WWTPs.
Residence time and fate owing to viral RNA in natural waters needs further research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
UNICEF, INDIA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
It is not required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
To show the importance of the work in a better manner.
Data Availability
All data is included in the paper.
